Call for a Free Phone Consultation

Recent blog posts

IL injury lawyerWhen medical devices are defective or do not function correctly, patients can suffer serious injuries. In these situations, injury victims may be able to take legal action against the manufacturer of a device that was designed or manufactured incorrectly, and they may be able to receive compensation for injuries or illnesses that were caused by unsafe medical products. Hernia mesh implants are one type of product that has been linked to serious injuries and health issues, and recently, victims have been able to recover compensation from the manufacturers of these products.

Hernias occur when an organ or tissue protrudes through a weak spot in the muscle or connective tissue that surrounds it. Hernia mesh is designed to reinforce the weakened area and prevent hernias from recurring. These devices are usually made of plastic, and they are implanted into the body to hold the hernia in place. Hernia mesh can be used in multiple different types of hernia repairs, including abdominal hernias, groin hernias, and Hiatal hernias.

While hernia mesh can be an effective treatment for hernias, it can also cause serious complications. Some types of hernia mesh have been found to erode or break down, and this can cause damage to the surrounding tissues, leading to pain and infections. Small pieces of plastic may cause damage to organs near the hernia, or they may migrate to other parts of the body, leading to issues such as inflammation, organ perforation, or intestinal blockage. These issues can be very painful, and they may result in permanent damage to multiple bodily systems.


chicago drug defect lawyerFor years, Zantac was considered to be an effective treatment for heartburn, acid reflux, ulcers, and other gastrointestinal issues. However, Zantac and ranitidine, the generic equivalent of the drug, were taken off the market in 2020. This was done in response to studies that discovered that the drug could break down and form a substance that has been linked to multiple types of cancer. Because of the wide use of Zantac, millions of people may have been exposed to this substance, potentially causing them to experience serious illnesses. Numerous lawsuits have been filed against the manufacturers of Zantac and ranitidine, and in the coming months, these cases will begin being heard in courts.

What Is the Current Status of Zantac Litigation?

People who have suffered injuries or damages that were related to their use of Zantac may be able to pursue product liability lawsuits against the drug’s manufacturers. As of 2022, multiple state-level lawsuits have been filed, and over 2,000 federal cases are also being pursued. The federal lawsuits have been combined into multi-district litigation (MDL). A class action lawsuit is scheduled to begin in August 2022, and bellwether trials in the MDL cases are expected to commence in October 2022 and early 2023.

Lawsuits are being pursued against multiple companies that have manufactured and sold Zantac. GSK, formerly known as GlaxoSmithKline, originally launched Zantac in the 1980s, and Sanofi owned the rights to the over-the-counter version of the drug. Other companies have also released products containing ranitidine, including Pfizer, Johnson & Johnson, Haleon, and Boehringer Ingelheim. Through lawsuits, users of the drugs may be able to show that these companies knowingly allowed a dangerous drug to be sold to consumers.


chicago infant formula injury lawyerThe ongoing baby formula shortage has focused the nation’s attention on the safety of our baby formula supply. While supply chain issues and high demand played a role in the shortage, another major factor was the recall of certain types of formula following reports of bacterial infections and subsequent plant closures. Cronobacter bacteria, which has been blamed for the death of two infants, was the cause of recent recalls and shutdowns. This adds to the concern about the safety of baby formula in the wake of necrotizing enterocolitis (NEC) cases across the country. 

NEC and Baby Formula

While not related to this latest recall, Abbott, Mead Johnson, and other manufacturers have been the subject of lawsuits over their cow-milk-based formulas, including the popular Similac and Enfamil brands. This is due to the risk that cow-milk-based formulas pose to premature infants. Babies who were born premature have been shown to be more at risk of NEC. Their intestines may not be developed enough to handle cow-milk-based formulas and become inflamed as a result, raising the risk of NEC. Studies have shown this risk for several decades. However, manufacturers of cow-milk-based formula have continued to be marketed to premature or low birth weight infants without warnings and are even still used at hospitals despite the risks being known. 

Babies who are breast-fed or given a mix of breast milk and formula are at a much lesser risk of contracting NEC. While NEC only affects about one out of every 10,000 full-term infants, one out of every 1,000 premature babies are affected. It leads to further inflammation of the intestines, bacterial infections, and tissue damage that can be fatal in 2 of ten cases. Treatments for NEC typically start with an IV to deliver fluid, then the infant will be treated with antibiotics. Abdominal surgery may be necessary to correct complications from NEC. Infants that survive may have long-term health problems. 


chicago roundup lawsuit attorneyOn Monday, June 11, the United States Supreme Court took no action regarding a bid by German pharmaceutical and chemical company Bayer to have legal claims against it related to Roundup weedkiller dismissed. This specific case is an appeal of a $25 million award in the state of California to Edwin Hardeman, who blamed his cancer on decades of Roundup use. The Biden administration has urged the court not to hear Bayer’s appeal, reversing course from the previous administration. The lack of action leaves the possibility that the court will hear the case. The closely-watched case could impact how Roundup lawsuits are handled across the country.

Roundup Background and Ongoing Cases

Roundup is a popular weed-killing chemical that has been used in the United States for decades by homeowners, landscapers, and other workers. One of its ingredients, glyphosate, has been linked in studies to harmful effects in humans such as cancer, including non-Hodgkin’s lymphoma. This type of cancer can lead to tumors in the lymph nodes, spleen, tonsils, and bone marrow. The tumors may spread to other parts of the body, including the brain, liver, and digestive system. Non-Hodgkin’s lymphoma can be fatal if proper treatment is not provided before the cancer spreads.

The previous manufacturer of Roundup, Monsanto, knew of the potentially harmful side effects while continuing to sell the product. This has resulted in legal action against Bayer, which paid $63 billion to buy Monsanto in 2018.


shutterstock_1454880986.jpgLate last month, a federal appeals court heard oral arguments regarding a legal shield for the family who owns Purdue Pharma from lawsuits related to OxyContin, a prescription opioid that has been linked to the nation’s opioid overdose epidemic. In March of this year, the billionaire Sacker family reached a tentative deal with a number of states that were resisting Purdue’s bankruptcy plan—a deal that was seen as a major step toward putting a small piece of the family’s fortune toward substance abuse treatment programs across the country.

As part of the deal, the Sacklers would contribute up to $6 billion to assist communities in addressing the damage caused by the opioid crisis. In return for their contribution, the family was hoping to end current and future claims related to Purdue’s prescription opioid products. Now it seems that the 2nd U.S. Circuit Court of Appeals is hesitant to extend protections to the Sacklers, as they have not filed for personal bankruptcy protection.

Exploring the Limits of Bankruptcy Protection

While oral arguments were being presented, the three-judge panel raised questions about the reach of the bankruptcy court in protecting the non-bankrupt family. Purdue claims that the family needs to be protected from lawsuits in order to secure the funding for settlements related to opioid cases. One of the judges warned attorneys for Purdue by saying, “Please don’t shoot yourself in the foot by saying it is the contributions of the Sacklers that make this plan lawful.”


chicago 3m earplug lawsuit lawyerCurrently, the product manufacturer 3M is fighting a large number of lawsuits from plaintiffs who have suffered hearing loss and related injuries after using earplugs the company provided to the U.S. military. Plaintiffs have alleged that the 3M earplugs in question, known as Combat Arms Earplugs Version 2 or CAEv2, did not provide sufficient protection against loud sounds that could damage the ears, especially since 3M did not provide the military with proper instructions to ensure that earplugs would be used correctly by their users. Some recent verdicts have indicated that mass tort litigation against 3M may be likely to succeed, and those who have been injured by these products may be able to receive large amounts of compensation.

Recent Multi-Million-Dollar 3M Earplugs Verdicts

Juries have decided in favor of plaintiffs in two recent trials that concluded in March of 2022. The first verdict involved a man who served in the Army National Guard for a relatively short period of time, including combat duty in Afghanistan. Even though his use of 3M earplugs was limited, he suffered hearing loss and tinnitus. The jury in his case awarded him $8 million.

The other case involved an Army veteran who served in the Army for a total of 21 years. During this time, he used 3M earplugs between 2006 and 2017. Even though these earplugs were primarily used during training, his continued exposure to loud noises throughout his years of service and the lack of protection provided by the earplugs led him to suffer permanent hearing loss, as well as severe tinnitus. The jury in his case awarded him $50 million, which is the second-highest verdict in a 3M earplugs trial to date.



Many people are aware that asbestos can be dangerous. Unfortunately, the effects of asbestos exposure may not become known until decades after the exposure occurred. Mesothelioma is one of the most serious issues that can be caused by the inhalation of asbestos, and this form of cancer can be very difficult to treat. Patients who are diagnosed with mesothelioma will want to understand the potential treatments that may be available, their prognosis and life expectancy, and whether they can take legal action to address the circumstances that led to their asbestos exposure.

Types of Mesothelioma Treatment

Mesothelioma is a form of cancer that affects the lining of cavities in the chest and abdomen. This condition will often occur because a person has inhaled asbestos particles that have become lodged in the lungs or entered the bloodstream. Pleural mesothelioma is the most common type of mesothelioma, and it will affect the lining around the lungs. Other types of mesothelioma include peritoneal mesothelioma that occurs in the lining around the abdominal cavity or pericardial mesothelioma that affects the lining around the heart.

Back to Top